Systemic Immune-Inflammation Index (SII) and Neutrophil-Lymphocyte Ratio (NLR) as Systemic Inflammatory Predictors in the Diagnosis of Bullous Pemphigoid and Pemphigus Vulgaris
Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
,
Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
,
Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
1 Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
2 Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
3 Department of Dermatology and Venerology, First Hospital of Jilin University, Changchun, China
Introduction: Autoimmune blistering skin disorders such as Bullous Pemphigoid and Pemphigus Vulgaris present diagnostic challenges. The Systemic Immune-Inflammation Index (SII) and Neutrophil-Lymphocyte Ratio (NLR), are inflammatory markers used to assess the body’s immune-inflammatory response. Objectives: The study aims to evaluate the significance of hematologic markers, specifically the Systemic Immune-Inflammation Index (SII) and Neutrophil-Lymphocyte Ratio (NLR), as diagnostic predictors of bullous pemphigoid (BP) and pemphigus vulgaris (PV). Methods: A retrospective study of 64 patients (36 with BP and 28 with PV). Patient clinical data: age, gender, complete blood count, autoimmune antibody levels (Dsg1, 3 and BP180, 230), IgE and C-reactive protein, and history of hypertension, diabetes, brain infarction, and coronary heart disease. The data was analyzed using SPSS. Results: The study involved 36 (56.3%) diagnosed with bullous pemphigoid (BP) and 28 (43.75%) with pemphigus vulgaris (PV). The average age in BP was 71 ± 8 and 52 ± 13 in PV. Laboratory findings showed high levels of Dsg1, Dsg3, neutrophil count, and lymphocyte count in PV, while high levels of eosinophils with a significant increase in C-reactive protein (CRP) in BP. Blood biomarkers, including NLR, PLR, SII, MPV, CRP, and IgE, proved an overall of 84.4% in disease prediction. Dsg1, Dsg3, BP180, and BP230 showed an overall of 88.1%. No significant relationship was noted between NLR, SII, and patients with comorbidities. Conclusion: The study highlights the diagnostic potential of SII and NLR in addition to hematologic markers in BP and PV, emphasizing their role in early diagnosis and therapeutic interventions, requiring further validation in larger patient cohorts.
Hammers, C.M. and Stanley, J.R. (2016) Mechanisms of Disease: Pemphigus and Bullous Pemphigoid. Annual Review of Pathology : Mechanisms of Disease , 11, 175-197. https://doi.org/10.1146/annurev-pathol-012615-044313
Egami, S., Yamagami, J. and Amagai, M. (2020) Autoimmune Bullous Skin Diseases, Pemphigus and Pemphigoid. The Journal of Allergy and Clinical Immunology , 145, 1031-1047. https://doi.org/10.1016/j.jaci.2020.02.013
Nousari, H.C. and Anhalt, G.J. (1999) Pemphigus and Bullous Pemphigoid. The Lancet , 354, 667-672. https://doi.org/10.1016/S0140-6736(99)03007-X
Popescu, I., Statescu, L., Vata, D., Andrese, E., Patrascu, A., Grajdeanu, I.-A., et al. (2019) Pemphigus Vulgaris—Approach and Management (Review). Experimental and Therapeutic Medicine , 18, 5056-5060. https://doi.org/10.3892/etm.2019.7964
Wang, Q., Qi, R., Li, J., Lin, F., Han, X., Liang, X., et al. (2022) A Retrospective Study on 464 Bullous Pemphigoid Patients in Northeast China. Chinese Medical Journal , 135, 875-877. https://doi.org/10.1097/CM9.0000000000001744
Amonchaisakda, N. and Aiempanakit, K. (2020) Clinical Characteristics, Mortality, and Prognostic Factors for Bullous Pemphigoid in a Thai Population. Medicine , 99, e22850. https://doi.org/10.1097/MD.0000000000022850
Di Lernia, V., Casanova, D.M., Goldust, M. and Ricci, C. (2020) Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment. Dermatology Practical & Conceptual , 10, e2020050.
Kridin, K. and Schmidt, E. (2021) Epidemiology of Pemphigus. JID Innovations , 1, Article 100004. https://doi.org/10.1016/j.xjidi.2021.100004
Maverakis, E., Bustos, I., Patel, F., Wilken, R., Patel, F., Sultani, H., et al. (2015) Pathophysiology of Autoimmune Bullous Diseases: Nature versus Nurture. Indian Jou r nal of Dermatology , 62, 262-267. https://doi.org/10.4103/0019-5154.159620
Kridin, K. and Ludwig, R.J. (2018) The Growing Incidence of Bullous Pemphigoid: Overview and Potential Explanations. Frontiers in Medicine , 5, Article 220. https://doi.org/10.3389/fmed.2018.00220
Askin, O., Ozkoca, D., Kutlubay, Z., et al . (2020) A Retrospective Analysis of Pemphigus Vulgaris Patients: Demographics, Diagnosis, Co-Morbid Diseases and Treatment Modalities Used. Northern Clinics of Istanbul , 7, 597-602.
Cao, P., Xu, W. and Zhang, L. (2022) Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review. Frontiers in Imm u nology , 13, Article 928621. https://doi.org/10.3389/fimmu.2022.928621
Systemic Immune-Inflammation Index (SII) and Neutrophil-Lymphocyte Ratio (NLR) as Systemic Inflammatory Predictors in the Diagnosis of Bullous Pemphigoid and Pemphigus Vulgaris — Oak Academic Publishing
Damoiseaux, J. (2013) Bullous Skin Diseases: Classical Types of Autoimmune Diseases. Scientifica , 2013, Article ID: 457982. https://doi.org/10.1155/2013/457982
Borradori, L., Van Beek, N., Feliciani, C., Tedbirt, B., Antiga, E., Bergman, R., et al. (2022) Updated S2 K Guidelines for the Management of Bullous Pemphigoid Initiated by the European Academy of Dermatology and Venereology (EADV). Jou r nal of the European Academy of Dermatology and Venereology , 36, 1689-1704. https://doi.org/10.1111/jdv.18220
Siddig, O., Mustafa, M.B., Kordofani, Y., Gibson, J. and Suleiman, A.M. (2021) The Epidemiology of Autoimmune Bullous Diseases in Sudan between 2000 and 2016. PLOS ONE , 16, e0254634. https://doi.org/10.1371/journal.pone.0254634
Lee, J., Seiffert-Sinha, K., Attwood, K. and Sinha, A.A. (2019) A Retrospective Study of Patient-Reported Data of Bullous Pemphigoid and Mucous Membrane Pemphigoid from a US-Based Registry. Frontiers in Immunology , 10, Article 2219. https://doi.org/10.3389/fimmu.2019.02219
Rosi-Schumacher, M., Baker, J., Waris, J., Seiffert-Sinha, K. and Sinha, A.A. (2023) Worldwide Epidemiologic Factors in Pemphigus Vulgaris and Bullous Pemphigoid. Frontiers in Immunology , 14, Article 1159351. https://doi.org/10.3389/fimmu.2023.1159351
Yang, Y.W., Chen, Y.H., Xirasagar, S. and Lin, H.C. (2011) Increased Risk of Stroke in Patients with Bullous Pemphigoid: A Population-Based Follow-Up Study. Stroke , 42, 319-323. https://doi.org/10.1161/STROKEAHA.110.596361
Ceyhun, H.A. and Gürbüzer, N. (2022) New Hematological Parameters as Inflammatory Biomarkers: Systemic Immune Inflammation Index, Platerethritis, and Platelet Distribution Width in Patients with Adult Attention Deficit Hyperactivity Disorder. Advances in Neurodevelopmental Disorders , 6, 211-223. https://doi.org/10.1007/s41252-022-00258-6
Taghipour, K., Chi, C.-C., Vincent, A., Groves, R.W., Venning, V. and Wojnarowska, F. (2010) The Association of Bullous Pemphigoid with Cerebrovascular Disease and Dementia: A Case-Control Study. Archives of Dermatological Research , 146, 1251-1254. https://doi.org/10.1001/archdermatol.2010.322
Khosravani, S., Handjani, F., Alimohammadi, R. and Saki, N. (2017) Frequency of Neurological Disorders in Bullous Pemphigoid Patients: A Cross-Sectional Study. International Scholarly Research Notices , 2017, Article ID: 6053267. https://doi.org/10.1155/2017/6053267
Tarazona, M.J.M., de Macedo Mota Bressan, A.N.C., Gripp, A.C., Unterstell, N. and Bressan, A.L. (2015) Bullous Pemphigoid and Neurological Disease: Statistics from a Dermatology Service. Anais Brasileiros de Dermatologia , 90, 280-282. https://doi.org/10.1590/abd1806-4841.20153334
Bech, R., Kibsgaard, L. and Vestergaard, C. (2018) Comorbidities and Treatment Strategies in Bullous Pemphigoid: An Appraisal of the Existing Litterature. Fro n tiers in Medicine , 5, Article 238. https://doi.org/10.3389/fmed.2018.00238
Sánchez-García, V., Pérez-Alcaraz, L., Belinchón-Romero, I. and Ramos-Rincón, J.M. (2022) Comorbidities in Patients with Autoimmune Bullous Disorders: Hospital-Based Registry Study. Life , 12, Article 595. https://doi.org/10.3390/life12040595
Rai, P. (2023) Role of Neutrophil-to-Lymphocyte, Neutrophil-to-Eosinophil and Platelet-to-Lymphocyte Ratios in the Diagnosis of Bullous Pemphigoid and Pemphigus Disease. The Indian Journal of Pathology and Microbiology , 66, 70-74. https://doi.org/10.4103/ijpm.ijpm_410_21
Liu, C.C., Ko, H.J., Liu, W.S., Hung, C.L., Hu, K.C., Yu, L.Y., et al. (2019) Neutrophil-to-Lymphocyte Ratio as a Predictive Marker of Metabolic Syndrome. Medicine , 98, e17537. https://doi.org/10.1097/MD.0000000000017537
Marzano, A.V., Tedeschi, A., Spinelli, D., Fanoni, D., Crosti, C. and Cugno, M. (2009) Coagulation Activation in Autoimmune Bullous Diseases. Clinical and E x perimental Immunology , 158, 31-36. https://doi.org/10.1111/j.1365-2249.2009.03989.x
Saschenbrecker, S., Karl, I., Komorowski, L., Probst, C., Dähnrich, C., Fechner, K., et al. (2019) Serological Diagnosis of Autoimmune Bullous Skin Diseases. Frontiers in Immunology , 10, Article 1974. https://doi.org/10.3389/fimmu.2019.01974
Muhammed, N., Korgaonkar, S., Pradhan, V. and Khopkar, U.S. (2021) A Cross-Sectional Study to Correlate Disease Severity in Bullous Pemphigoid Patients with Serum Levels of Autoantibodies against BP180 and BP230. Indian Dermatol o gy Online Journal , 12, 696-700. https://doi.org/10.4103/idoj.IDOJ_813_20
Wang, J., Liu, H., Wang, Z., Pan, Q. and Zhang, F. (2023) Analysis of the Autoimmune Response to BP180 in Chinese Stroke Patients. Anais Brasileiros de Derm a tologia , 98, 13-16. https://doi.org/10.1016/j.abd.2022.01.012
Persson, M.S.M., Harman, K.E., Vinogradova, Y., Langan, S.M., Hippisley-Cox, J., Thomas, K.S., et al. (2021) Incidence, Prevalence and Mortality of Bullous Pemphigoid in England 1998-2017: A Population-Based Cohort Study. British Journal of Dermatology , 184, 68-77. https://doi.org/10.1111/bjd.19022
Van Beek, N., Zillikens, D. and Schmidt, E. (2021) Bullous Autoimmune Dermatoses. Deutsches Ärzteblatt International , 118, 413-420. https://doi.org/10.3238/arztebl.m2021.0136
Gornowicz-Porowska, J., Seraszek-Jaros, A., Bowszyc-Dmochowska, M., Kaczmarek, E., Pietkiewicz, P., Bartkiewicz, P., et al. (2017) Accuracy of Molecular Diagnostics in Pemphigus and Bullous Pemphigoid: Comparison of Commercial and Modified Mosaic Indirect Immunofluorescence Tests as Well as Enzyme-Linked Immunosorbent Assays. Advances in Dermatology and Allergology , 34, 21-27. https://doi.org/10.5114/ada.2017.65617
Qian, Y., Zhai, E., Zhang, Z., Dai, W., Peng, J., Chen, J., et al. (2020) Systemic Immune-Inflammation Index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with Synchronic Colorectal Peritoneal Carcinomatosis. Journal of Cancer , 11, 5264-5272. https://doi.org/10.7150/jca.46446
Nam, K.W., Kwon, H.M., Jeong, H.Y., Park, J.H. and Kwon, H. (2022) Systemic Immune-Inflammation Index Is Associated with White Matter Hyperintensity Volume. Scientific Reports , 12, Article No. 7379. https://doi.org/10.1038/s41598-022-11575-0